Friday 29th March 2024

ingestor_04-24-2020-22-53-26_ago-schmitt

Missouri Attorney General Eric Schmitt announced that on April 30, Missouri and other states reached an agreement with Indivior PLC and Indivior Inc. (collectively “Indivior”) to settle allegations that Indivior falsely and aggressively marketed and promoted the drug Suboxone, resulting in improper expenditures of state Medicaid funds.

Suboxone is a drug approved for use by patients recovering from opioid addiction to avoid or reduce withdrawal symptoms while they undergo treatment. Suboxone and its active ingredient, buprenorphine, are powerful opioids.

Indivior will pay a total of $300 million to the collective states to resolve the civil fraud allegations impacting Medicaid and other government healthcare programs, of which approximately $204 million will go to Medicaid.

The states will receive a total of nearly $91 million as their share of the Medicaid recovery with the remaining paid to the federal government. As part of the settlement, the state of Missouri will receive $712,107.57 in restitution and damages.

The Attorney General’s Medicaid Fraud Control Unit handled this case.